Browsing by Author UM, SH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 7 of 7 < previous 
TitleAuthor(s)Issue DateViews
 
Interim report for a phase II, multi-centre, dose-escalating study of LB80380/ANA380 in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
Proceeding/Conference:Journal of Hepatology
Lai, CLHan, KHYoon, SKUM, SHYuen, MFKim, HSKim, HRChung, HCKim, CRHsyu, PAverett, DKim, J
2005
132
 
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
Proceeding/Conference:Journal of Hepatology
Lai, CLHan, KHYoon, SKUm, SHYuen, MFKim, HSKim, HRChung, HCKim, CRHsyu, PAverett, DWorland, SKim, J
2006
195
 
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
Journal:Gut
Lai, CLAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JAHan, KHYuen, RMF
2013
111
 
A phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis B
Proceeding/Conference:Hepatology
Lai, CLAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NWKwon, YOSohn, JHLee, JYPark, HEKim, JAHan, KHYuen, MF
2011
97
 
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study
Journal:Journal of Hepatology
Yuen, RMFAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JALai, CLHan, KH
2015
51
 
Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis B
Proceeding/Conference:Hepatology
Lai, CLAhh, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JAHan, KHYuen, MF
2011
39
Showing results 2 to 7 of 7 < previous